Lance A Berry
First SEC filing: March 10, 2025 · Latest: March 10, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 14, 2026 | AORT | S | 715 | $28.55 | $20,413 | 210,112 Direct | -0.34% | Disposed | -20.8% (price as of 2026-10-05) |
| May 19, 2026 | TMCI | A | 30,000 | · | · | 74,593 Direct | +67.28% | Acquired | (price as of 2026-10-05) |
| March 3, 2026 | AORT | S | 6,316 | $37.78 | $238,618 | 210,827 Direct | -2.91% | Disposed | -40.2% (price as of 2026-10-05) |
| March 2, 2026 | AORT | A | 40,874 | · | · | 217,143 Direct | +23.19% | Acquired | (price as of 2026-10-05) |
| March 2, 2026 | AORT | S | 5,178 | $38.02 | $196,868 | 176,269 Direct | -2.85% | Disposed | -40.5% (price as of 2026-10-05) |
| Feb. 24, 2026 | AORT | S | 4,485 | $35.69 | $160,070 | 143,965 Direct | -3.02% | Disposed | -36.6% (price as of 2026-10-05) |
| Feb. 24, 2026 | AORT | A | 37,482 | · | · | 181,447 Direct | +26.04% | Acquired | (price as of 2026-10-05) |
| Feb. 23, 2026 | AORT | S | 4,981 | $37.59 | $187,236 | 148,450 Direct | -3.25% | Disposed | -39.9% (price as of 2026-10-05) |
| May 20, 2025 | TMCI | A | 23,917 | · | · | 44,593 Direct | +115.68% | Acquired | (price as of 2026-10-05) |
| March 6, 2025 | AORT | S | 4,909 | $24.80 | $121,743 | 153,431 Direct | -3.10% | Disposed | -8.8% (price as of 2026-10-05) |
| March 6, 2025 | AORT | A | 48,100 | · | · | 158,340 Direct | +43.63% | Acquired | (price as of 2026-10-05) |
| Feb. 28, 2025 | AORT | A | 34,435 | · | · | 110,240 Direct | +45.43% | Acquired | (price as of 2026-10-05) |
| Feb. 24, 2025 | AORT | S | 3,259 | $27.31 | $89,003 | 75,805 Direct | -4.12% | Disposed | -17.2% (price as of 2026-10-05) |
| May 21, 2024 | TMCI | A | 33,260 | · | · | 33,260 Direct | · | Acquired | (price as of 2026-10-05) |
| May 21, 2024 | TMCI | A | 15,091 | · | · | 20,676 Direct | +270.21% | Acquired | (price as of 2026-10-05) |
| Feb. 23, 2024 | AORT | A | 37,000 | · | · | 79,064 Direct | +87.96% | Acquired | (price as of 2026-10-05) |
| Dec. 6, 2023 | AORT | A | 93,633 | · | · | 93,633 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 6, 2023 | AORT | A | 42,064 | $17.83 | $750,001 | 42,064 Direct | · | Acquired | 26.8% (price as of 2026-10-05) |
| May 23, 2023 | TMCI | A | 2,753 | · | · | 5,585 Direct | +97.21% | Acquired | (price as of 2026-10-05) |
| May 23, 2023 | TMCI | A | 6,305 | · | · | 6,305 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 1, 2022 | TMCI | A | 19,439 | · | · | 19,439 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 1, 2022 | TMCI | A | 2,832 | · | · | 2,832 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 21, 2024 | TMCI | Stock Option (Right to Buy) | Common Stock | $4.97 | May 21, 2034 | 33,260 | Acquired |
| Dec. 6, 2023 | AORT | Stock Option (Right to Buy) | Common Stock | $17.83 | Dec. 6, 2030 | 93,633 | Acquired |
| May 23, 2023 | TMCI | Stock Option (Right to Buy) | Common Stock | $26.34 | May 23, 2033 | 6,305 | Acquired |
| Oct. 1, 2022 | TMCI | Stock Option (Right to Buy) | Common Stock | $22.07 | Oct. 1, 2032 | 19,439 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $526,377 | · | · | · | $400,194 | · | $90,536 | $2,977,091 |
| 2024 | $500,000 | · | · | · | $390,000 | · | $184,053 | $2,574,033 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.